Eugenol Activity Against Escherichia coli and Staphylococcus aureus: Biofilm Disruption and Additive Interactions with Antibiotics
Current Microbiology · 2026
DOI: 10.1007/s00284-026-05201-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Victor Alves Carneiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biofilms and Antimicrobial Agents (LaBAM/NUBEM), INTA University Center - UNINTA, 62.050-100, Sobral, Ceará, Brazil. victor.carneiro@un…. Hauptthemen laut MEDLINE: Biofilms, Staphylococcus aureus, Anti-Bacterial Agents, Escherichia coli. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centro Universitário Inta.
Abstract (Originalsprache)
The emergence of multidrug-resistant bacteria and their ability to form biofilms represent significant challenges in infection control. This study evaluated the antibacterial and antibiofilm activities of eugenol (Eug) against Escherichia coli and Staphylococcus aureus from food and clinical sources. Antibacterial activity was assessed using disk diffusion, broth microdilution (MIC/MBC), and bacterial growth kinetics. Antibiofilm activity was measured by crystal violet staining, CFU enumeration, and scanning electron microscopy (SEM). Checkerboard assays evaluated the combinatorial effect of Eug with ciprofloxacin and oxacillin. Eug exhibited inhibition zones of 13–22 mm and MIC/MBC values of 1000–2000 µg/mL. Subinhibitory concentrations significantly delayed bacterial growth. Biofilm biomass was reduced by up to 90% in E. coli and 80% in S. aureus , with SEM confirming structural alterations. Checkerboard assays revealed additive interactions with antibiotics. These findings provide additional evidence of Eug’s antibacterial properties and support further investigation into its combinatorial effects with antibiotics against biofilm-associated challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Biofilms and Antimicrobial Agents (LaBAM/NUBEM), INTA University Center - UNINTA, 62.050-100, Sobral, Ceará, Brazil. victor.carneiro@uninta.edu.br.
- Faculty of Medicine, INTA University Center (UNINTA), Vilebaldo Aguiar 133, Fortaleza, Ceará, 60192-010, Brazil. victor.carneiro@uninta.edu.br.
- Laboratory of Biofilms and Antimicrobial Agents (LaBAM/NUBEM), INTA University Center - UNINTA, 62.050-100, Sobral, Ceará, Brazil.
- Northeast Network of Biotechnology Program (RENORBIO), State University of Ceará, Campus Itaperi, Fortaleza, 60714-903, Brazil.
- Center for Exact, Natural and Technological Sciences, State University of the Tocantina Region of Maranhão, Imperatriz, 65901-480, Brazil.
Förderung
- Centro Universitário Inta
Zitieren
APA
Carneiro, V. A., Azevedo, Á. M. A., da Silva, B. F., Melo, R. S., Pereira, A. M. G., Cavalcante, R. M. B., & Junior, F. E. A. C. (2026). Eugenol Activity Against Escherichia coli and Staphylococcus aureus: Biofilm Disruption and Additive Interactions with Antibiotics. Current Microbiology. https://doi.org/10.1007/s00284-026-05201-9
Vancouver
Carneiro VA, Azevedo ÁMA, da Silva BF, Melo RS, Pereira AMG, Cavalcante RMB, et al. Eugenol Activity Against Escherichia coli and Staphylococcus aureus: Biofilm Disruption and Additive Interactions with Antibiotics. Current Microbiology. 2026. doi:10.1007/s00284-026-05201-9
BibTeX
@article{Carneiro2026,
author = {Carneiro, Victor Alves and Azevedo, Águida Maria Albuquerque and da Silva, Benise Ferreira and Melo, Ramaiana Soares and Pereira, Antônio Mateus Gomes and Cavalcante, Rafaela Mesquita Bastos and Junior, Francisco Eduardo Aragão Catunda},
title = {Eugenol Activity Against Escherichia coli and Staphylococcus aureus: Biofilm Disruption and Additive Interactions with Antibiotics},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-026-05201-9}
}
EUVIMED